Table 6.

Characteristics of primary AML patients.

	Diagnose	Gender	Age(year)	FAB type	Cytogenetics	Molecular
AML#1	de novo	female	33	M4	46, XX	WT1 MLL-AF9
AML#2	de novo	male	52	M2	46, XY	BCR-ABL NPM1
AML#3	de novo	male	50	M5b	46, XY	IDH2-R140Q
AML#4	refractory	female	59	M4a	46, XX	FLT3-ITD
AML#5	refractory	male	51	M2a	46, XY	IDH2